Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. (Q30361444)

20 June 2017

Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. (English)

1 reference

20 June 2017

0 references

0 references

prevention of HIV/AIDS

0 references

1 reference

1 reference

7

Helen Rees

0 references

Peter Piot

16

object named as

Peter Piot

1 reference

20 June 2017

Alexandra Jones

1

0 references

Ide Cremin

object named as

Ide Cremin

2

0 references

Mark Dybul

17

object named as

Mark Dybul

1 reference

20 June 2017

8

Timothy Hallett

1 reference

20 June 2017

Fareed Abdullah

3

1 reference

20 June 2017

John Idoko

4

1 reference

20 June 2017

Peter Cherutich

5

1 reference

20 June 2017

Nduku Kilonzo

6

1 reference

20 June 2017

Helen Rees

7

1 reference

20 June 2017

Kevin O'Reilly

9

1 reference

20 June 2017

Florence Koechlin

10

1 reference

20 June 2017

Bernhard Schwartlander

11

1 reference

20 June 2017

Barbara de Zalduondo

12

1 reference

20 June 2017

Susan Kim

13

1 reference

20 June 2017

Jonathan Jay

14

1 reference

20 June 2017

Jacqueline Huh

15

1 reference

20 June 2017

language of work or name

English

0 references

publication date

14 April 2014

1 reference

20 June 2017

1 reference

20 June 2017

384

1 reference

20 June 2017

9939

1 reference

20 June 2017

272-279

1 reference

HIV decline associated with behavior change in eastern Zimbabwe

20 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Uganda's HIV prevention success: the role of sexual behavior change and the national response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Condom use to prevent incident STDs: the validity of self-reported condom use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Association between condom use and HIV infection: a randomised study of self reported condom use measures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Implications of laboratory tests of condom integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Condom effectiveness in reducing heterosexual HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Effectiveness of condoms in preventing HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Assessment of population-level effect of Avahan, an HIV-prevention initiative in India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

The 100% condom use programme in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Condoms and prevention of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Female condom technology: new products and regulatory issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Short-term acceptability of the PATH Woman's Condom among couples at three sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Voluntary medical male circumcision: a framework analysis of policy and program implementation in eastern and southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Can devices for adult male circumcision help bridge the implementation gap for HIV prevention services?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Assessment of changes in risk behaviors during 3 years of posttrial follow-up of male circumcision trial participants uncircumcised at trial closure in Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Circumcision and male-to-male sexual transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Prevention of HIV-1 infection with early antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

HIV treatment as prevention: the utility and limitations of ecological observation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

HIV-1 drug resistance resulting from antiretroviral therapy far exceeds that from pre-exposure prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

HIV and risk environment for injecting drug users: the past, present, and future.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Structural approaches to HIV prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

HIV prevention. Halting HIV/AIDS epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Making HIV prevention programmes work.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Coming to terms with complexity: a call to action for HIV prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Mapping HIV clustering: a strategy for identifying populations at high risk of HIV infection in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

HIV: know your epidemic, act on its politics.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Men who have sex with men and HIV/AIDS in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Towards an improved investment approach for an effective response to HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Mathematical models in the evaluation of health programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Economics of antiretroviral treatment vs. circumcision for HIV prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

A tale of two-component generalised HIV epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Behaviour change in generalised HIV epidemics: impact of reducing cross-generational sex and delaying age at sexual debut

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Successes and challenges of HIV prevention in men who have sex with men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Drug Development and the FDA's Critical Path Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

What led to the Nigerian boycott of the polio vaccination campaign?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

More and better information to tackle HIV epidemics: towards improved HIV incidence assays

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Monitoring the AIDS epidemic using HIV prevalence data among young women attending antenatal clinics: prospects and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Evaluation of large-scale combination HIV prevention programs: essential issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Implementation science for the prevention and treatment of HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

Combination HIV prevention: significance, challenges, and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962230-8

7 January 2021

10.1016/S0140-6736(13)62230-8

Identifiers

DOI

1 reference

release_cqpfvg2wmjdlfntjtkpcsmk6xi

20 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cqpfvg2wmjdlfntjtkpcsmk6xi

24 November 2022

mapped directly with Wikidata item

1 reference